Company intelligence / Profile preview

Akern

Florence/Pontassieve, Tuscany, Italyakern.com ↗

Ownership: Private
Development stage: Commercial

Overview

Akern has over four decades of experience as a leader in bioimpedance analysis for body composition. Its devices and software are widely used for clinical assessment of hydration and nutritional status across cardiology, nephrology/dialysis, nutrition support, fitness/sports medicine. The company’s innovations include real-time BIVA analysis devices and cloud-based data platforms. In June 2022 it was acquired by PharmaNutra to expand strategic synergies.

Therapeutic areas: Metabolic DisordersCardiovascularNephrologyOther
Modalities: DeviceData analysis software (Bioimpedance analyzers)
Industry: Physiological Monitoring

Partnerships

IRRIV – International Renal Research Institute of Vicenza

Beyond the preview

Go deeper on Akern.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Akern.

Explore the full profile